Amplia Therapeutics Limited Share Price OTC Markets
Stocks
INNMF
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1150 USD | +43.75% |
|
-.--% | +45.75% |
| Market Cap | 6.93Cr 4.81Cr 4.21Cr 3.88Cr 3.59Cr 6.82Cr 459.22Cr 46Cr 18Cr 225.51Cr 18Cr 18Cr 781.12Cr | P/E 2027 * |
-5.87x | P/E 2028 * | -22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 5.38Cr 3.73Cr 3.27Cr 3.01Cr 2.79Cr 5.29Cr 356.5Cr 36Cr 14Cr 175.07Cr 14Cr 14Cr 606.41Cr | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 4.78x |
| Free-Float |
84.81% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | +43.75% | ||
| 1 month | +15.00% | ||
| 3 months | -17.86% | ||
| 6 months | -4.17% | ||
| Current year | +45.75% |
| 1 month | 0.08 |  | 0.12 |
| Current year | 0.06 | | 0.27 |
| 1 year | 0.05 | | 0.27 |
| 3 years | 0.02 | | 0.27 |
| 5 years | 0.02 | | 0.27 |
| 10 years | 0.01 | | 1.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 05/12/2022 | |
Hamish George
DFI | Director of Finance/CFO | - | 01/10/2021 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 02/09/2015 |
Warwick Tong
CHM | Chairman | - | 25/05/2018 |
| Director/Board Member | - | 04/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +43.75% | -.--% | - | - | 4.81Cr | |
| -0.38% | -3.44% | +71.35% | +128.83% | 5.7TCr | |
| +4.91% | -0.19% | +73.70% | +92.14% | 5.36TCr | |
| +1.48% | +5.97% | +22.59% | +495.47% | 2.56TCr | |
| -0.59% | -4.68% | -16.82% | -12.99% | 2.35TCr | |
| +4.37% | +2.77% | +50.19% | +1.58% | 1.94TCr | |
| +2.01% | +2.99% | +40.72% | -24.93% | 1.81TCr | |
| -6.84% | +2.18% | +203.03% | +348.11% | 1.65TCr | |
| +7.26% | +2.91% | +52.92% | - | 1.41TCr | |
| +1.76% | +2.24% | +29.57% | +195.70% | 1.44TCr | |
| Average | +5.84% | +0.86% | +58.58% | +152.99% | 2.69TCr | |
| Weighted average by Cap. | +1.70% | -0.31% | +59.56% | +143.77% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 1Cr 69.43L 60.73L 56.01L 51.82L 98.36L 66Cr 6.71Cr 2.63Cr 33Cr 2.61Cr 2.55Cr 112.72Cr |
| Net income | -1.16Cr -80.53L -70.45L -64.97L -60.11L -1.14Cr -77Cr -7.78Cr -3.05Cr -38Cr -3.02Cr -2.96Cr -130.76Cr | -36L -24.99L -21.86L -20.16L -18.66L -35.41L -24Cr -2.41Cr -94.65L -12Cr -93.83L -91.8L -41Cr |
| Net Debt | -1.55Cr -1.08Cr -94.14L -86.81L -80.32L -1.52Cr -102.71Cr -10Cr -4.08Cr -50Cr -4.04Cr -3.95Cr -174.72Cr | -2.15Cr -1.49Cr -1.31Cr -1.2Cr -1.11Cr -2.11Cr -142.48Cr -14Cr -5.65Cr -70Cr -5.6Cr -5.48Cr -242.35Cr |
Employees
-
| Date | Price | Change | Volume |
|---|
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1350AUD
Average target price
0.4200AUD
Spread / Average Target
+211.11%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
- INNMF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
